tiprankstipranks
Trending News
More News >
Gasporox AB (SE:GPX)
:GPX
Sweden Market

Gasporox AB (GPX) AI Stock Analysis

Compare
0 Followers

Top Page

SE:GPX

Gasporox AB

(GPX)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
kr8.50
▲(14.86% Upside)
Action:ReiteratedDate:03/19/26
The score is held back primarily by weak financial performance—ongoing losses and a sharp 2025 (annual) profitability and operating cash flow setback. Technicals are supportive with price above major moving averages and moderate momentum, but valuation is constrained by negative earnings and no dividend support.
Positive Factors
Improved leverage
Material debt reduction to zero by 2025 meaningfully lowers refinancing and interest risk. A lighter leverage profile gives the company more runway to pursue product development, service expansion and integration projects, and reduces near-term liquidity pressure amid continuing losses.
Multi‑year revenue growth
Sustained top-line growth over multiple years shows persistent market demand for its inspection systems. Durable hardware sales plus after‑sales service and integration projects create a basis for recurring revenues that can scale fixed-cost absorption and improve margin potential over the medium term.
Specialized NDT technology
Proprietary laser-based inspection tech targets regulated food and pharma processes where quality controls are mission-critical. This specialization creates technical barriers, higher switching costs and aftermarket service opportunities, supporting durable competitive positioning and pricing power in niche end markets.
Negative Factors
Persistent losses
Chronic unprofitability erodes equity and constrains strategic flexibility. Persistent negative EBIT means the business has yet to demonstrate sustainable margins, forcing reliance on external capital or cost restructuring to reach self-sufficiency and limiting long-term return prospects for shareholders.
Inconsistent cash generation
Volatile and historically negative free cash flow indicates the business is not consistently self-funding. Irregular operating cash undermines ability to invest in R&D, maintain service levels, and absorb shocks without raising external capital, increasing dilution and financing risk over the medium term.
2025 profitability shock
A pronounced operating deterioration in 2025 signals margin vulnerability from cost inflation, adverse mix or one-offs. Such a shock reduces visibility into sustainable profitability, raises questions about unit economics and scalability, and implies management must fix structural issues to restore durable earnings.

Gasporox AB (GPX) vs. iShares MSCI Sweden ETF (EWD)

Gasporox AB Business Overview & Revenue Model

Company DescriptionGasporox AB (publ) develops and commercializes products based on laser spectroscopy. It offers GasSpect series of sensors for headspace analysis; LeakSpect series of sensors for detecting leaks of carbon dioxide from packages; MicroLab laboratory instruments for research and development of packages and materials; and GPX1500, a non-intrusive oxygen headspace gas analyzer. The company also provides measurement services for package and process evaluations. Gasporox AB (publ) was founded in 2005 and is based in Lund, Sweden.
How the Company Makes MoneyGasporox makes money mainly by selling measurement and inspection systems used in industrial quality assurance and process control. Key revenue streams include (1) product revenue from the sale of hardware systems (e.g., in-line/at-line inspection equipment for package leak detection and related gas-measurement instruments), (2) recurring and ancillary revenue tied to those installations such as service, maintenance, calibration, spare parts, and customer support, and (3) project/application work where systems are adapted or integrated into customer production lines (typically involving engineering, installation, and validation activities). If the company has material revenue from software subscriptions, licensing, or specific named partnerships, that information is null because it is not available from the provided context.

Gasporox AB Financial Statement Overview

Summary
Strong multi-year revenue growth is outweighed by persistent net losses and consistently negative EBIT. The 2025 (annual) deterioration—deeply negative gross profit/EBIT and negative operating cash flow—raises near-term sustainability risk despite improved leverage.
Income Statement
34
Negative
Revenue has grown strongly over the multi-year period (from 2020 to 2024), and 2024 showed continued growth. However, profitability remains weak: net income is negative every year shown, and EBIT is also consistently negative. A key concern is the sharp deterioration in 2025 (annual) where gross profit and EBIT turned deeply negative versus prior years, suggesting either cost pressure, mix issues, or one-offs that materially hurt operating performance.
Balance Sheet
58
Neutral
Leverage looks manageable and has improved: total debt fell from 8.7M (2023) to 2.3M (2024) and is reported at 0 in 2025 (annual). Equity remains positive, providing a cushion. That said, equity has declined from 2024 to 2025 (annual), consistent with ongoing losses, and returns on equity are negative where provided—highlighting that the balance sheet strength is being eroded by lack of profitability.
Cash Flow
41
Neutral
Cash generation is inconsistent. Operating cash flow was positive in 2023 and 2024, but turned negative again in 2025 (annual), which raises near-term funding risk if losses persist. Free cash flow is negative in multiple years (2021–2024), indicating the business has not been self-funding, and the 2025 free cash flow figure is reported as 0 alongside a -100% growth rate, which signals volatility and/or reporting noise rather than a clear, durable improvement.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue31.57M34.10M31.43M21.45M15.74M
Gross Profit-7.98M33.10M30.69M22.45M16.26M
EBITDA-1.55M-347.00K946.00K-3.25M-4.69M
Net Income-7.71M-2.68M-1.25M-4.56M-5.39M
Balance Sheet
Total Assets50.62M39.97M43.52M44.43M37.37M
Cash, Cash Equivalents and Short-Term Investments6.65M6.81M10.62M14.56M14.27M
Total Debt0.002.32M8.73M8.43M0.00
Total Liabilities30.76M13.28M20.33M19.99M8.74M
Stockholders Equity19.86M26.69M23.19M24.44M28.63M
Cash Flow
Free Cash Flow0.00-3.52M-3.98M-8.28M-9.91M
Operating Cash Flow-4.72M4.36M3.34M-1.19M-3.39M
Investing Cash Flow-7.65M-7.52M-7.04M-7.01M-6.52M
Financing Cash Flow12.21M-648.00K-240.00K8.50M-53.00K

Gasporox AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price7.40
Price Trends
50DMA
7.05
Positive
100DMA
7.11
Positive
200DMA
7.30
Positive
Market Momentum
MACD
0.20
Negative
RSI
60.25
Neutral
STOCH
48.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:GPX, the sentiment is Positive. The current price of 7.4 is above the 20-day moving average (MA) of 7.14, above the 50-day MA of 7.05, and above the 200-day MA of 7.30, indicating a bullish trend. The MACD of 0.20 indicates Negative momentum. The RSI at 60.25 is Neutral, neither overbought nor oversold. The STOCH value of 48.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:GPX.

Gasporox AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
50
Neutral
kr74.64M-9.07-15.54%-263.54%
47
Neutral
kr57.57M-2.20-37.93%-82.93%94.83%
47
Neutral
kr699.74M-42.57-9.00%-1.32%51.89%
46
Neutral
kr8.16M-0.29-153.88%-0.75%65.47%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:GPX
Gasporox AB
7.98
-0.12
-1.48%
SE:FING.B
Fingerprint Cards
15.20
-9.20
-37.70%
SE:RO
Rolling Optics
SE:INSP
Insplorion AB
0.10
-0.35
-77.06%
SE:ACCON
Acconeer AB
9.19
3.84
71.78%
SE:UNIBAP
Unibap AB
5.44
-0.32
-5.56%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026